Arcturus Therapeutics Holdings Inc.
ARCT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$80,941 | -$29,725 | $9,349 | -$203,674 |
| Dep. & Amort. | $3,544 | $2,957 | $1,527 | $1,193 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $37,988 | $34,649 | $30,611 | $28,915 |
| Change in WC | -$20,809 | $7,381 | -$12,557 | $32,625 |
| Other Non-Cash | $471 | -$33,361 | $3,063 | $5,898 |
| Operating Cash Flow | -$59,747 | -$18,099 | $31,993 | -$135,043 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$648 | -$2,901 | -$7,726 | -$3,406 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$648 | -$2,901 | -$7,726 | -$3,406 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$27,364 | -$5,000 | $46,599 |
| Stock Issued | $682 | $609 | $411 | $515 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4,736 | $2,668 | $1,730 | $902 |
| Financing Cash Flow | $5,418 | -$24,087 | -$2,859 | $48,016 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$54,977 | -$45,087 | $21,408 | -$90,433 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $348,890 | $393,977 | $372,569 | $463,002 |
| End Cash | $293,913 | $348,890 | $393,977 | $372,569 |
| Free Cash Flow | -$60,395 | -$21,000 | $24,267 | -$138,449 |